Drug interactions for the following drug(s)
Applies to: Fluorouracil 20 MG/ML Topical Solution <> Spironolactone 50 MG Oral Tablet
The metabolism of Fluorouracil can be decreased when combined with Spironolactone.
Applies to: gabapentin 300 MG Oral Capsule <> gabapentin 300 MG Oral Capsule
The risk or severity of adverse effects can be increased when Gabapentin is combined with Gabapentin enacarbil.
Applies to: Flecainide Acetate 150 MG Oral Tablet <> Amlodipine 5 MG Oral Tablet
Amlodipine may increase the arrhythmogenic activities of Flecainide.
Applies to: Spironolactone 50 MG Oral Tablet <> Amlodipine 5 MG Oral Tablet
The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Spironolactone.
Applies to: Flecainide Acetate 150 MG Oral Tablet <> Fluorouracil 20 MG/ML Topical Solution
The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Flecainide.
Applies to: Spironolactone 50 MG Oral Tablet <> gabapentin 300 MG Oral Capsule
Spironolactone may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: Fluorouracil 20 MG/ML Topical Solution <> Spironolactone 50 MG Oral Tablet
Drug1 (rxcui = 310379, name = fluorouracil 20 MG/ML Topical Solution, tty = SCD). Drug2 (rxcui = 198223, name = spironolactone 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to fluorouracil, Drug2 is resolved to spironolactone and interaction asserted in DrugBank between Fluorouracil and Spironolactone.
Applies to: gabapentin 300 MG Oral Capsule <> gabapentin 300 MG Oral Capsule
Drug1 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug1 is resolved to gabapentin, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Gabapentin and Gabapentin enacarbil. Drug1 is resolved to gabapentin enacarbil, Drug2 is resolved to gabapentin and interaction asserted in DrugBank between Gabapentin enacarbil and Gabapentin.
Applies to: Flecainide Acetate 150 MG Oral Tablet <> Amlodipine 5 MG Oral Tablet
Drug1 (rxcui = 886671, name = flecainide acetate 150 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 197361, name = amlodipine 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to flecainide, Drug2 is resolved to amlodipine and interaction asserted in DrugBank between Flecainide and Amlodipine.
Applies to: Spironolactone 50 MG Oral Tablet <> Amlodipine 5 MG Oral Tablet
Drug1 (rxcui = 198223, name = spironolactone 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 197361, name = amlodipine 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to spironolactone, Drug2 is resolved to amlodipine and interaction asserted in DrugBank between Spironolactone and Amlodipine.
Applies to: Flecainide Acetate 150 MG Oral Tablet <> Fluorouracil 20 MG/ML Topical Solution
Drug1 (rxcui = 886671, name = flecainide acetate 150 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 310379, name = fluorouracil 20 MG/ML Topical Solution, tty = SCD). Drug1 is resolved to flecainide, Drug2 is resolved to fluorouracil and interaction asserted in DrugBank between Flecainide and Fluorouracil.
Applies to: Spironolactone 50 MG Oral Tablet <> gabapentin 300 MG Oral Capsule
Drug1 (rxcui = 198223, name = spironolactone 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug1 is resolved to spironolactone, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Spironolactone and Gabapentin enacarbil.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.